Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

BUY
$5.65 - $14.9 $43,166 - $113,836
7,640 Added 6.58%
123,772 $748,000
Q2 2021

Aug 12, 2021

SELL
$9.75 - $18.42 $453,901 - $857,524
-46,554 Reduced 28.62%
116,132 $1.51 Million
Q1 2021

May 17, 2021

BUY
$14.7 - $30.57 $2.39 Million - $4.97 Million
162,686 New
162,686 $2.51 Million

Others Institutions Holding GRCL

About Gracell Biotechnologies Inc.


  • Ticker GRCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,674,096
  • Description
  • Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the tre...
More about GRCL
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.